https://retacompare.com/news/exploring-urological-effects-in-obesity-implications-for-glp-1-research 2026-10-31T01:30:42.534Z RetatrutideCompare en 2026-10-31T01:30:42.534Z Exploring Urological Effects in Obesity: Implications for GLP-1 Research Weight Loss, Retatrutide https://retacompare.com/news/experimental-drug-retatrutide-shows-potential-in-reducing-sleep-apnea-symptoms 2026-10-30T19:49:25.000Z RetatrutideCompare en 2026-10-30T19:49:25.000Z Experimental Drug Retatrutide Shows Potential in Reducing Sleep Apnea Symptoms Weight Loss, Retatrutide https://retacompare.com/news/exploring-fatigue-in-glp-1-agonist-use-and-recovery-strategies 2026-10-30T18:50:02.000Z RetatrutideCompare en 2026-10-30T18:50:02.000Z Exploring Fatigue in GLP-1 Agonist Use and Recovery Strategies Patient Experiences, Retatrutide https://retacompare.com/news/study-links-glp-1-agonists-to-reduced-cancer-risk-in-nondiabetics 2026-10-30T18:22:36.000Z RetatrutideCompare en 2026-10-30T18:22:36.000Z Study Links GLP-1 Agonists to Reduced Cancer Risk in Nondiabetics Clinical Trials, Retatrutide https://retacompare.com/news/rivus-to-present-animal-study-on-glp-1-s-muscle-sparing-effects 2026-10-30T18:00:37.000Z RetatrutideCompare en 2026-10-30T18:00:37.000Z Rivus to Present Animal Study on GLP-1's Muscle-Sparing Effects Clinical Trials, Retatrutide https://retacompare.com/news/exploring-glp-1-agonists-link-to-breast-cancer-risks 2026-10-30T13:38:32.000Z RetatrutideCompare en 2026-10-30T13:38:32.000Z Exploring GLP-1 Agonists' Link to Breast Cancer Risks Market News, Retatrutide https://retacompare.com/news/lilly-s-strong-earnings-ease-concerns-over-glp-1-pricing-pressures 2026-10-30T11:50:00.000Z RetatrutideCompare en 2026-10-30T11:50:00.000Z Lilly's Strong Earnings Ease Concerns Over GLP-1 Pricing Pressures Market News, Retatrutide https://retacompare.com/news/retatrutide-shows-superior-results-to-ozempic-in-t2d-weight-loss-a1c-control 2026-10-30T10:00:37.000Z RetatrutideCompare en 2026-10-30T10:00:37.000Z Retatrutide Shows Superior Results to Ozempic in T2D Weight Loss, A1c Control Clinical Trials, Retatrutide https://retacompare.com/news/exploring-new-roles-for-glp-1-receptor-agonists-beyond-diabetes-management 2026-10-30T04:00:00.000Z RetatrutideCompare en 2026-10-30T04:00:00.000Z Exploring New Roles for GLP-1 Receptor Agonists Beyond Diabetes Management Clinical Trials, Retatrutide https://retacompare.com/news/retatrutide-emerges-as-a-potentially-powerful-weight-loss-drug 2026-10-30T03:13:00.000Z RetatrutideCompare en 2026-10-30T03:13:00.000Z Retatrutide Emerges as a Potentially Powerful Weight Loss Drug Weight Loss, Retatrutide https://retacompare.com/news/retatrutide-outperforms-ozempic-in-diabetes-trial-but-raises-side-effect-concerns 2026-10-30T00:18:14.000Z RetatrutideCompare en 2026-10-30T00:18:14.000Z Retatrutide Outperforms Ozempic in Diabetes Trial but Raises Side Effect Concerns Clinical Trials, Retatrutide https://retacompare.com/news/exploring-glp-1-agonists-for-substance-use-disorder-treatment 2026-10-30T00:00:00.000Z RetatrutideCompare en 2026-10-30T00:00:00.000Z Exploring GLP-1 Agonists for Substance Use Disorder Treatment Clinical Trials, Retatrutide https://retacompare.com/news/glp-1-agonists-explored-in-obesity-related-heart-failure-with-preserved-ejection-fraction 2026-10-30T00:00:00.000Z RetatrutideCompare en 2026-10-30T00:00:00.000Z GLP-1 Agonists Explored in Obesity-Related Heart Failure with Preserved Ejection Fraction Clinical Trials, Retatrutide https://retacompare.com/news/impact-of-glp-1-drugs-on-us-healthcare-and-public-health-explored 2026-10-29T23:51:59.000Z RetatrutideCompare en 2026-10-29T23:51:59.000Z Impact of GLP-1 Drugs on US Healthcare and Public Health Explored Market News, Retatrutide